LyellA.. Toxic epidermal necrolysis: an eruption resembling scalding of the skin.Br J Dermatol1956; 68: 355–61.
2.
RoujeauJ-C, GuillaumeJ-C, FabreJ-P. Toxic epidermal necrolysis (Lyell syndrome): Incidence and drug etiology in France, 1981-1985.Arch Dermatol1990; 126: 37–42.
3.
HalebianPH, MaddenMR, FinklesteinJL. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.Ann Surg1986; 204: 503–12.
4.
HeimbachDM, LorenLH, MarvinJA. Toxic epidermal necrolysis: A step forward in treatment.JAMA1987; 257: 2171–5.
5.
RevuzJ., PensoD., RoujeauJ-C. Toxic epidermal necrolysis: Clinical findings and prognosis factors in 87 patients.Arch Dermatol1987; 123: 1160–5.
6.
GuillaumeJ-C, RoujeauJ-C, RevuzJ.. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).Arch Dermatol1987; 123: 1166–70.
CorreiaO., DelgadoL., RamosJP. Cutaneous T-cell recruitment in toxic epidermal necrolysis: further evidence of CD8+ lymphocyte involvement.Arch Dermatol1993; 129: 466–8.
9.
HagdrupH., TonnesenE., ClemmensenO.. Abnormalities of lymphocyte function and phenotypic pattern in a case of toxic epidermal necrolysis.Acta Derm Venereol (Stockh)1992; 72: 268–70.
10.
HengMCY, AllenSG. Efficacy of cyclophosphamide in toxic epidermal necrolysis: Clinical and pathophysiologic aspects.J Am Acad Dermatol1991; 25: 778–86.
11.
VilladaG., RoujeauJ-C, ClericiT.. Immunopathology of toxic epidermal necrolysis: Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: An immunopathologic study of five cases.Arch Dermatol1992; 128: 50–3.
12.
AvakianR., FlowersFP, AraujoOE. Toxic epidermal necrolysis: A review.J Am Acad Dermatol1991; 25: 69–79.
13.
DaviesDM. Textbook of Adverse Drug Reactions, 3rd edn.New York: Oxford University Press, 1985.
Tegelberg-StassenM.J.A.M., van VlotenWA, Baart de la FailleH.. Management of nonstaphylococcal toxic epidermal necrolysis: Follow-up study of 16 case histories.Dermatologica1990; 180: 124–9.
16.
HuqNS, SproatJE. Baclofen and trazodone: New culprits in toxic epidermal necrolysis.Can J Plast Surg1996; 4: 123–124.
RzanyB., HamoudaO., SchopfE.. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with acquired immunodeficiency syndrome in Germany.Arch Dermatol1993; 129: 1059.
19.
SaiagP., CaumesE., ChosidowO.. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus.J Am Acad Dermatol1992; 26: 567–74.
20.
PorteousDM, BergerTG. Severe cutaneous reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.Arch Dermatol1991; 127: 740–1.
